These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24142804)

  • 1. Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
    Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
    J Cardiovasc Transl Res; 2014 Mar; 7(2):226-31. PubMed ID: 24142804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial.
    Barbato E; Herman A; Benit E; Janssens L; Lalmand J; Hoffer E; Chenu P; Guédès A; Missault L; Pirenne B; Cardinal F; Vercauteren S; Wijns W
    Atherosclerosis; 2015 Jun; 240(2):351-4. PubMed ID: 25875387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents.
    Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H
    BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents.
    Mitsutake Y; Ueno T; Yokoyama S; Sasaki K; Sugi Y; Toyama Y; Koiwaya H; Ohtsuka M; Nakayoshi T; Itaya N; Chibana H; Kakuma T; Imaizumi T
    JACC Cardiovasc Interv; 2012 Sep; 5(9):966-73. PubMed ID: 22995884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.
    Wöhrle J; Höher M; Nusser T; Hombach V; Kochs M
    Can J Cardiol; 2003 Apr; 19(5):495-500. PubMed ID: 12717484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents.
    Montone RA; Niccoli G; Vergni F; Vetrugno V; Russo M; Mangiacapra F; Fracassi F; Porto I; Leone AM; Burzotta F; D'Amario D; Aurigemma C; Trani C; Lanza GA; Crea F
    Eur J Prev Cardiol; 2018 Sep; 25(13):1360-1370. PubMed ID: 29785885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor inhibition improves endothelial function in patients with stable angina.
    Muller O; Bartunek J; Hamilos M; Berza CT; Mangiacapra F; Ntalianis A; Vercruysse K; Duby C; Wijns W; De Bruyne B; Heyndrickx GR; Vanderheyden M; Holz JB; Barbato E
    J Cardiovasc Transl Res; 2013 Jun; 6(3):364-70. PubMed ID: 23233321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, double-blind, placebo-controlled study investigating the effects of inorganic nitrate on vascular function, platelet reactivity and restenosis in stable angina: protocol of the NITRATE-OCT study.
    Rathod KS; Jones DA; Van-Eijl TJ; Tsang H; Warren H; Hamshere SM; Kapil V; Jain AK; Deaner A; Poulter N; Caulfield MJ; Mathur A; Ahluwalia A
    BMJ Open; 2016 Dec; 6(12):e012728. PubMed ID: 27998900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: double-blind and open-label studies.
    Messin R; Cerreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Adv Ther; 2006; 23(1):107-30. PubMed ID: 16644612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis.
    Ong P; Athanasiadis A; Perne A; Mahrholdt H; Schäufele T; Hill S; Sechtem U
    Clin Res Cardiol; 2014 Jan; 103(1):11-9. PubMed ID: 23995322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of sirolimus-eluting stent versus bare metal stent evaluation of the coronary endothelial dysfunction in the same patient presenting with multiple coronary artery lesions: the CREDENTIAL study.
    Mischie AN; Nazzaro MS; Fiorilli R; De Felice F; Musto C; Confessore P; Parma A; Boschetti C; Violini R
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E184-91. PubMed ID: 23359371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells mobilisation after percutaneous coronary intervention: a pilot study.
    Santas-Álvarez M; Rodiño-Janeiro BK; Paradela-Dobarro B; López-Otero D; Viñuela-Roldán JE; Castiñeiras-Landeira MI; González-Juanatey JR; Trillo-Nouche R; Álvarez E
    Br J Biomed Sci; 2016 Oct; 73(4):194-200. PubMed ID: 27310267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preprocedural fractional flow reserve and microvascular resistance predict increased hyperaemic coronary flow after elective percutaneous coronary intervention.
    Murai T; Kanaji Y; Yonetsu T; Lee T; Matsuda J; Usui E; Araki M; Niida T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):233-242. PubMed ID: 27219714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.